(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||
(Address of principal executive offices) | (Zip Code) | |||||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Exhibit No. | Description | |
Press Release of the Company dated February 5, 2020 | ||
104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. | |
Dated: February 6, 2020 | THE ENSIGN GROUP, INC. | |||
By: | /s/ Suzanne D. Snapper | |||
Suzanne D. Snapper | ||||
Chief Financial Officer and Executive Vice President | ||||
Exhibit No. | Description | |
Press Release of the Company dated February 5, 2020 | ||
104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. | |

▪ | GAAP diluted earnings per share for the quarter was $0.49, representing a 48.5%(1) increase over the prior year quarter; and spin-adjusted diluted earnings per share for the fourth quarter was $0.60(2), an increase of 39.5%(3) from prior year quarter and an increase of 33.3%(3) sequentially over the third quarter. |
▪ | GAAP diluted earnings per share for the year was $1.97 and adjusted diluted earnings per share for the year was $2.24(2), an increase of 29.5%(4) over the prior year. |
▪ | Consolidated GAAP revenues for the year were $2.29 billion and consolidated adjusted revenues for the year were $2.28 billion(2), an increase of 19.9%(4) over the prior year. |
▪ | Total skilled services revenue was $1.9 billion for the year, an increase of 15.2% over the prior year, and was $530.2 million for the quarter, an increase of 20.0% over the prior year quarter and 9.1% sequentially over the third quarter(5). |
▪ | Same store occupancy was 80.3%, an increase of 216 basis points over the prior year; and same store skilled managed care and Medicare revenue was up 8.4% and 4.9%, respectively. |
▪ | Transitioning occupancy was 78.1%, an increase of 279 basis points over the prior year; and transitioning skilled managed care revenue was up 15.7%. |
▪ | Same store skilled days increased by 3.0% and transitioning skilled days increased by 4.9%, both for the year. |
▪ | Same store skilled days increased by 8.8% and total same store skilled days increased by 3.1% basis points, both sequentially over the third quarter; |
▪ | GAAP net income was $91.7 million(1), an increase of 54.1%(1) over the prior year, and spin-adjusted net income for the year was $109.0 million(3), an increase of 40.5%(3) over the prior year. |
▪ | St. Joseph’s Villa Independent Living, a 58-unit independent living operation in Salt Lake City, Utah |
▪ | Treasure Hills Healthcare and Rehabilitation Center, a skilled nursing facility with 110 skilled nursing beds, located in Harlingen, Texas; |
▪ | Keller Oaks Healthcare Center, a skilled nursing facility with 146 skilled nursing beds, located in Keller, Texas; |
▪ | Kirkwood Manor, a skilled nursing facility with 162 skilled nursing beds, located in New Braunfels, Texas; |
▪ | Hunters Pond Rehabilitation and Healthcare, a skilled nursing facility with 128 skilled nursing beds, located in San Antonio, Texas; |
▪ | Pecan Valley Rehabilitation and Healthcare, a skilled nursing facility with 124 skilled nursing beds, located in San Antonio, Texas; |
▪ | Westover Hills Rehabilitation and Healthcare, a skilled nursing facility with 124 skilled nursing beds, located in San Antonio, Texas; |
▪ | Crestwood Health and Rehabilitation Center, a skilled nursing facility with 112 skilled nursing beds and an assisted living center with 36 assisted living units, located in Willis Point, Texas; |
▪ | Beacon Harbor Healthcare and Rehabilitation, a skilled nursing facility with 190 skilled nursing beds, located in Rockwall, Texas; |
▪ | Rowlett Health and Rehabilitation Center, a skilled nursing facility with 150 skilled nursing beds, located in Rowlett, Texas; |
▪ | Pleasant Manor Healthcare and Rehabilitation, a skilled nursing facility with 126 skilled nursing beds, located in Waxahachie, Texas; |
▪ | Mission Palms Post Acute, a skilled nursing facility with 160 skilled nursing beds located in Mesa, Arizona; and |
▪ | The Healthcare Center at Patriot Heights, a healthcare campus with 59 skilled nursing beds and 158 independent living units located in San Antonio, Texas. |
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenue from continuing operations | $ | 560,191 | $ | 462,439 | $ | 2,036,524 | $ | 1,754,601 | |||||||
Expense from continuing operations | |||||||||||||||
Cost of services | 443,382 | 372,066 | 1,620,628 | 1,418,249 | |||||||||||
Return of unclaimed class action settlement | — | — | — | (1,664 | ) | ||||||||||
Rent—cost of services | 31,511 | 29,898 | 124,789 | 117,676 | |||||||||||
General and administrative expense | 32,251 | 25,013 | 110,873 | 90,563 | |||||||||||
Depreciation and amortization | 13,354 | 11,544 | 51,054 | 44,864 | |||||||||||
Total expenses | 520,498 | 438,521 | 1,907,344 | 1,669,688 | |||||||||||
Income from operations from continuing operations | 39,693 | 23,918 | 129,180 | 84,913 | |||||||||||
Other income (expense): | |||||||||||||||
Interest expense | (4,149 | ) | (3,711 | ) | (15,662 | ) | (15,182 | ) | |||||||
Interest income | 792 | 549 | 2,649 | 2,016 | |||||||||||
Other expense, net | (3,357 | ) | (3,162 | ) | (13,013 | ) | (13,166 | ) | |||||||
Income before provision for income taxes | 36,336 | 20,756 | 116,167 | 71,747 | |||||||||||
Provision for income taxes | 9,010 | 2,653 | 23,954 | 12,685 | |||||||||||
Net income from continuing operations, net of tax | 27,326 | 18,103 | 92,213 | 59,062 | |||||||||||
Net income from discontinued operations, net of tax | — | 8,456 | 19,473 | 33,466 | |||||||||||
Net income | 27,326 | 26,559 | 111,686 | 92,528 | |||||||||||
Less: | |||||||||||||||
Net (loss)/income attributable to noncontrolling interests | (68 | ) | 16 | 523 | (431 | ) | |||||||||
Net income attributable to discontinued noncontrolling interests | — | 183 | 629 | 595 | |||||||||||
Net (loss)/income attributable to noncontrolling interests | (68 | ) | 199 | 1,152 | 164 | ||||||||||
Net income attributable to The Ensign Group, Inc. | $ | 27,394 | $ | 26,360 | $ | 110,534 | $ | 92,364 | |||||||
Amounts attributable to the The Ensign Group, Inc. | |||||||||||||||
Income from continuing operations attributable to The Ensign Group, Inc. | 27,394 | 18,087 | 91,690 | 59,493 | |||||||||||
Income from discontinued operations, net of income tax | — | 8,273 | 18,844 | 32,871 | |||||||||||
Net income attributable to The Ensign Group, Inc. | $ | 27,394 | $ | 26,360 | $ | 110,534 | $ | 92,364 | |||||||
Net income per share attributable to The Ensign Group, Inc.: | |||||||||||||||
Basic: | |||||||||||||||
Continuing operations | $ | 0.51 | $ | 0.34 | $ | 1.72 | $ | 1.14 | |||||||
Discontinued operations | $ | — | $ | 0.16 | $ | 0.35 | $ | 0.64 | |||||||
Basic income per share attributable to The Ensign Group, Inc. | $ | 0.51 | $ | 0.50 | $ | 2.07 | $ | 1.78 | |||||||
Diluted: | |||||||||||||||
Continuing operations | $ | 0.49 | $ | 0.33 | $ | 1.64 | $ | 1.09 | |||||||
Discontinued operations | $ | — | $ | 0.15 | $ | 0.33 | $ | 0.61 | |||||||
Diluted income per share attributable to The Ensign Group, Inc. | $ | 0.49 | $ | 0.48 | $ | 1.97 | $ | 1.70 | |||||||
Weighted average common shares outstanding: | |||||||||||||||
Basic | 53,397 | 52,449 | 53,452 | 52,016 | |||||||||||
Diluted | 55,760 | 54,967 | 55,981 | 54,397 | |||||||||||
Three Months Ended December 31, 2019 | ||||||||||||
GAAP | Non-GAAP(1) | Pro Forma Non-GAAP Adjustments(2) | ||||||||||
Net revenue - continuing operations | $ | 560,191 | $ | 555,979 | $ | 555,979 | ||||||
Net revenue - discontinued operations | — | — | ||||||||||
Net revenue | $ | 560,191 | $ | 555,979 | ||||||||
Net income - continuing operations | $ | 27,394 | $ | 33,529 | $ | 33,529 | ||||||
Net income - discontinued operations | — | — | ||||||||||
Net income | $ | 27,394 | $ | 33,529 | ||||||||
Fully diluted EPS - continuing operations | $ | 0.49 | $ | 0.60 | $ | 0.60 | ||||||
Fully diluted EPS - discontinued operations | $ | — | $ | — | ||||||||
Fully diluted EPS | $ | 0.49 | $ | 0.60 | ||||||||
EBITDA - continuing operations | $ | 53,115 | $ | 60,430 | $ | 60,430 | ||||||
EBITDA - discontinued operations | — | — | ||||||||||
EBITDA | $ | 53,115 | $ | 60,430 | ||||||||
EBITDAR - continuing operations | $ | 91,498 | $ | 91,498 | ||||||||
EBITDAR - discontinued operations | — | |||||||||||
EBITDAR | $ | 91,498 | ||||||||||
Three Months Ended December 31, 2018 | ||||||||||||
GAAP | Non-GAAP(1) | Pro Forma Non-GAAP Adjustments(2) | ||||||||||
Net revenue - continuing operations | $ | 462,439 | $ | 445,455 | $ | 448,293 | ||||||
Net revenue - discontinued operations | 75,336 | 75,291 | ||||||||||
Net revenue | $ | 537,775 | $ | 520,746 | ||||||||
Net income - continuing operations | $ | 18,087 | $ | 21,254 | $ | 23,569 | ||||||
Net income - discontinued operations | 8,273 | 8,156 | ||||||||||
Net income | $ | 26,360 | $ | 29,410 | ||||||||
Fully diluted EPS - continuing operations | $ | 0.33 | $ | 0.39 | $ | 0.43 | ||||||
Fully diluted EPS - discontinued operations | $ | 0.15 | $ | 0.15 | ||||||||
Fully diluted EPS | $ | 0.48 | $ | 0.54 | ||||||||
EBITDA - continuing operations | $ | 35,446 | $ | 42,728 | $ | 45,973 | ||||||
EBITDA - discontinued operations | 11,001 | 11,543 | ||||||||||
EBITDA | $ | 46,447 | $ | 54,271 | ||||||||
Three Months Ended September 30, 2019 | ||||||||||||
GAAP | Non-GAAP(1) | Pro Forma Non-GAAP Adjustments(2) | ||||||||||
Net revenue - continuing operations | $ | 512,109 | $ | 509,541 | $ | 512,582 | ||||||
Net revenue - discontinued operations | 88,398 | 88,325 | ||||||||||
Net revenue | $ | 600,507 | $ | 597,866 | ||||||||
Net income - continuing operations | $ | 22,148 | $ | 22,447 | $ | 25,487 | ||||||
Net income - discontinued operations | 5,011 | 8,496 | ||||||||||
Net income | $ | 27,159 | $ | 30,943 | ||||||||
Fully diluted EPS - continuing operations | $ | 0.39 | $ | 0.40 | $ | 0.45 | ||||||
Fully diluted EPS - discontinued operations | $ | 0.09 | $ | 0.15 | ||||||||
Fully diluted EPS | $ | 0.48 | $ | 0.55 | ||||||||
EBITDA - continuing operations | $ | 43,814 | $ | 46,160 | $ | 50,286 | ||||||
EBITDA - discontinued operations | 8,781 | 12,324 | ||||||||||
EBITDA | $ | 52,595 | $ | 58,484 | ||||||||
EBITDAR - continuing operations | $ | 77,740 | $ | 81,866 | ||||||||
EBITDAR - discontinued operations | 18,173 | |||||||||||
EBITDAR | $ | 95,913 | ||||||||||
Year Ended December 31, 2019 | ||||||||||||
GAAP | Non-GAAP(1) | Pro Forma Non-GAAP Adjustments(2) | ||||||||||
Net revenue - continuing operations | $ | 2,036,524 | $ | 2,027,915 | $ | 2,037,010 | ||||||
Net revenue - discontinued operations | 249,039 | 248,713 | ||||||||||
Net revenue | $ | 2,285,563 | $ | 2,276,628 | ||||||||
Net income - continuing operations | $ | 91,690 | $ | 99,869 | $ | 108,990 | ||||||
Net income - discontinued operations | 18,844 | 25,688 | ||||||||||
Net income | $ | 110,534 | $ | 125,557 | ||||||||
Fully diluted EPS - continuing operations | $ | 1.64 | $ | 1.78 | $ | 1.95 | ||||||
Fully diluted EPS - discontinued operations | $ | 0.33 | $ | 0.46 | ||||||||
Fully diluted EPS | $ | 1.97 | $ | 2.24 | ||||||||
EBITDA - continuing operations | $ | 179,711 | $ | 195,645 | $ | 207,805 | ||||||
EBITDA - discontinued operations | 26,883 | 36,801 | ||||||||||
EBITDA | $ | 206,594 | $ | 232,446 | ||||||||
EBITDAR - continuing operations | $ | 319,513 | $ | 331,674 | ||||||||
EBITDAR - discontinued operations | 54,084 | |||||||||||
EBITDAR | $ | 373,597 | ||||||||||
Year Ended December 31, 2018 | ||||||||||||||||
GAAP | Non-GAAP(1) | Pro Forma Non-GAAP Adjustments(2) | Pro Forma Non-GAAP Adjustments(3) | |||||||||||||
Net revenue - continuing operations | $ | 1,754,601 | $ | 1,688,214 | $ | 1,699,568 | $ | 1,688,214 | ||||||||
Net revenue - discontinued operations | 286,058 | 285,838 | 210,546 | |||||||||||||
Net revenue | $ | 2,040,659 | $ | 1,974,052 | $ | 1,898,760 | ||||||||||
Net income - continuing operations | $ | 59,493 | $ | 68,319 | $ | 77,584 | $ | 68,319 | ||||||||
Net income - discontinued operations | 32,871 | 33,812 | $ | 25,654 | ||||||||||||
Net income | $ | 92,364 | $ | 102,131 | $ | 93,973 | ||||||||||
Fully diluted EPS - continuing operations | $ | 1.09 | $ | 1.26 | $ | 1.43 | $ | 1.26 | ||||||||
Fully diluted EPS - discontinued operations | $ | 0.61 | $ | 0.62 | 0.47 | |||||||||||
Fully diluted EPS | $ | 1.70 | $ | 1.88 | $ | 1.73 | ||||||||||
EBITDA - continuing operations | $ | 130,208 | $ | 147,988 | $ | 160,968 | $ | 147,988 | ||||||||
EBITDA - discontinued operations | 45,460 | 47,627 | 36,083 | |||||||||||||
EBITDA | $ | 175,668 | $ | 195,615 | $ | 184,071 | ||||||||||
(1) Refer to our reconciliation of GAAP to Non-GAAP financial information. | ||||||||||||||||
(2) Unaudited pro forma Non-GAAP results include adjustments of rental income, savings of general and administrative and interest expense as if the Spin-Off had occurred at the beginning of the period reported. | ||||||||||||||||
(3) Unaudited pro forma Non-GAAP results include results of continuing operations for four quarters and three quarters of discontinued operations to be comparable to 2019 Non-GAAP results. | ||||||||||||||||
December 31, | |||||||
2019 | 2018 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 59,175 | $ | 31,042 | |||
Accounts receivable—less allowance for doubtful accounts of $2,472 and $2,270 at December 31, 2019 and 2018, respectively | 308,985 | 251,915 | |||||
Investments—current | 17,754 | 8,682 | |||||
Prepaid income taxes | 739 | 6,219 | |||||
Prepaid expenses and other current assets | 24,428 | 19,576 | |||||
Assets held for sale - current | — | 1,859 | |||||
Current assets of discontinued operations | — | 28,779 | |||||
Total current assets | 411,081 | 348,072 | |||||
Property and equipment, net | 767,565 | 608,416 | |||||
Right-of-use assets | 1,046,901 | — | |||||
Insurance subsidiary deposits and investments | 30,571 | 36,168 | |||||
Escrow deposits | 14,050 | 7,271 | |||||
Deferred tax assets | 4,615 | 11,749 | |||||
Restricted and other assets | 26,207 | 18,459 | |||||
Intangible assets, net | 3,382 | 30,922 | |||||
Goodwill | 54,469 | 49,585 | |||||
Other indefinite-lived intangibles | 3,068 | 2,466 | |||||
Long-term assets of discontinued operations | $ | — | $ | 68,850 | |||
Total assets | $ | 2,361,909 | $ | 1,181,958 | |||
Liabilities and equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 44,973 | $ | 39,846 | |||
Accrued wages and related liabilities | 151,009 | 106,870 | |||||
Lease liabilities—current | 44,964 | — | |||||
Accrued self-insurance liabilities—current | 29,252 | 25,446 | |||||
Other accrued liabilities | 70,273 | 56,711 | |||||
Current maturities of long-term debt | 2,702 | 10,105 | |||||
Current liabilities of discontinued operations | — | 30,249 | |||||
Total current liabilities | 343,173 | 269,227 | |||||
Long-term debt—less current maturities | 325,217 | 233,135 | |||||
Long-term lease liabilities—less current portion | 973,983 | — | |||||
Accrued self-insurance liabilities—less current portion | 58,114 | 54,605 | |||||
Other long-term liabilities | 5,278 | 7,918 | |||||
Deferred gain related to sale-leaseback | — | 11,417 | |||||
Long-term liabilities of discontinued operations | — | 3,316 | |||||
Total equity | 656,144 | 602,340 | |||||
Total liabilities and equity | $ | 2,361,909 | $ | 1,181,958 | |||
Year Ended December 31, | |||||||
2019 | 2018 | ||||||
Net cash provided by (used in): | |||||||
Continuing operating activities | $ | 168,927 | $ | 170,152 | |||
Continuing investing activities | (224,030 | ) | (141,340 | ) | |||
Continuing financing activities | 83,278 | (70,345 | ) | ||||
Net (decrease) increase in cash from discontinued operations | (83 | ) | 30,279 | ||||
Net increase (decrease) in cash and cash equivalents | 28,092 | (11,254 | ) | ||||
Cash and cash equivalents beginning of period, including cash of discontinued operations | 31,083 | 42,337 | |||||
Cash and cash equivalents end of period, including cash of discontinued operations | $ | 59,175 | $ | 31,083 | |||
Less cash of discontinued operations at end of period | — | 41 | |||||
Cash and cash equivalents at end of period | $ | 59,175 | $ | 31,042 | |||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Net income from continuing operations | $ | 27,394 | $ | 18,087 | $ | 91,690 | $ | 59,493 | |||||||
Net income from discontinued operations, net of tax | — | 8,273 | 18,844 | 32,871 | |||||||||||
Net income attributable to The Ensign Group, Inc. | $ | 27,394 | $ | 26,360 | $ | 110,534 | $ | 92,364 | |||||||
Non-GAAP adjustments | |||||||||||||||
Results related to operations in the start-up phase(a) | — | 449 | — | 3,682 | |||||||||||
Return of unclaimed class action settlement | — | — | — | (1,664 | ) | ||||||||||
Share-based compensation expense(b) | 3,107 | 2,211 | 11,322 | 8,367 | |||||||||||
Results related to closed operations and operations not at full capacity(c) | 1,311 | 222 | 3,505 | 933 | |||||||||||
Acquisition related costs(d) | 132 | 10 | 277 | 322 | |||||||||||
Depreciation and amortization - patient base(e) | 260 | 79 | 521 | 154 | |||||||||||
General and administrative - Spin-Off transaction costs(f) | 464 | — | 464 | — | |||||||||||
COS - Impairment charges to fixed assets, net of gain on sale(g) | 1,732 | 4,632 | 329 | 4,632 | |||||||||||
COS - business interruption gains(h) | — | — | — | (675 | ) | ||||||||||
COS - impairment of goodwill and intangibles(i) | 941 | — | 941 | 3,177 | |||||||||||
Interest expense - write off of deferred financing fees(j) | 329 | — | 329 | — | |||||||||||
Provision for income taxes on Non-GAAP adjustments(k) | (2,141 | ) | (4,436 | ) | (9,509 | ) | (10,102 | ) | |||||||
Non-GAAP income from continuing operations | $ | 33,529 | $ | 21,254 | $ | 99,869 | $ | 68,319 | |||||||
Non-GAAP income from discontinued operations(l) | — | 8,156 | 25,688 | 33,812 | |||||||||||
Non-GAAP net income | $ | 33,529 | $ | 29,410 | $ | 125,557 | $ | 102,131 | |||||||
Average number of shares outstanding | 55,760 | 54,967 | 55,981 | 54,397 | |||||||||||
Diluted Earnings Per Share As Reported | |||||||||||||||
Continuing operations | $ | 0.49 | $ | 0.33 | $ | 1.64 | $ | 1.09 | |||||||
Discontinued operations | $ | — | $ | 0.15 | $ | 0.33 | $ | 0.61 | |||||||
Diluted income per share attributable to The Ensign Group, Inc. | $ | 0.49 | $ | 0.48 | $ | 1.97 | $ | 1.70 | |||||||
Adjusted Diluted Earnings Per Share | |||||||||||||||
Continuing operations | $ | 0.60 | $ | 0.39 | $ | 1.78 | $ | 1.26 | |||||||
Discontinued operations | $ | — | $ | 0.15 | $ | 0.46 | $ | 0.62 | |||||||
Diluted income per share attributable to The Ensign Group, Inc. | $ | 0.60 | $ | 0.54 | $ | 2.24 | $ | 1.88 | |||||||
Footnotes: | |||||||||||||||
(a) Represents operating results for start-up operations. | |||||||||||||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenue | $ | — | $ | (16,984 | ) | $ | — | $ | (66,386 | ) | |||||
Cost of services | — | 13,581 | — | 54,758 | |||||||||||
Rent | — | 3,619 | — | 14,347 | |||||||||||
Depreciation and amortization | — | 233 | — | 963 | |||||||||||
Total Non-GAAP adjustment | $ | — | $ | 449 | $ | — | $ | 3,682 | |||||||
(b) Represents share-based compensation expense incurred. | |||||||||||||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Cost of services | $ | 2,001 | $ | 1,379 | $ | 7,036 | $ | 5,183 | |||||||
General and administrative | 1,106 | 832 | 4,286 | 3,184 | |||||||||||
Total Non-GAAP adjustment | $ | 3,107 | $ | 2,211 | $ | 11,322 | $ | 8,367 | |||||||
(c) Represents results at closed operations and operations not at full capacity | |||||||||||||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenue | $ | (4,212 | ) | $ | — | $ | (8,609 | ) | $ | — | |||||
Cost of services | 4,708 | 137 | 10,289 | 601 | |||||||||||
Rent | 443 | 76 | 921 | 301 | |||||||||||
Depreciation and amortization | 372 | 9 | 904 | 31 | |||||||||||
Total Non-GAAP adjustment | $ | 1,311 | $ | 222 | $ | 3,505 | $ | 933 | |||||||
(d) Represents costs incurred to acquire an operation which are not capitalizable. | |||||||||||||||
(e) Included in depreciation and amortization are expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities. | |||||||||||||||
(f) Included in general and administrative expense are costs incurred in connection with the completed Spin-Off of our home health and hospice operations and substantially all of our senior living operations to a newly formed publicly traded company subsequent to the Spin-Off date. Expenses incurred prior to Spin-Off date are included in discontinued operations as an adjustment. | |||||||||||||||
(g) Impairment charges to fixed assets includes impairment charges of $1.7 million at one of our skilled nursing operations during the three months ended December 31, 2019. Additionally, included in the year ended December 31, 2019, impairment charges of $1.5 million at two of our senior living operations and at the skilled nursing operation mentioned, offset by the gain recognized for the sale of real estate of $2.9 million. | |||||||||||||||
(h) Business interruption recoveries related to insurance claims of the California fires that occurred in the fourth quarter of 2017. | |||||||||||||||
(i) Impairment charges to goodwill and intangible assets at our other ancillary operations and a skilled nursing operation. | |||||||||||||||
(j) Represents the write off of deferred financing fees associated with the amendment of the credit facility. | |||||||||||||||
(k) Represents an adjustment to the provision for income tax to our historical year to date effective tax rate of 25.0% for the three months and years ended December 31, 2019 and 2018. | |||||||||||||||
(l) Represents results of the home health, hospice and senior living operations we transferred to the Pennant Group, Inc. as a result of the Spin-Off. | |||||||||||||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenue | $ | — | $ | 75,291 | $ | 248,713 | $ | 285,838 | |||||||
Cost of services | — | (55,314 | ) | (185,963 | ) | (208,585 | ) | ||||||||
General and administrative expenses | — | (2,819 | ) | (8,037 | ) | (8,225 | ) | ||||||||
Rent | — | (5,432 | ) | (17,283 | ) | (20,805 | ) | ||||||||
Depreciation and amortization | — | (643 | ) | (2,367 | ) | (2,392 | ) | ||||||||
Interest income, net | — | 36 | 26 | 47 | |||||||||||
Provision for income taxes | — | (2,780 | ) | (8,772 | ) | (11,471 | ) | ||||||||
Non-controlling interest | — | (183 | ) | (629 | ) | (595 | ) | ||||||||
Non-GAAP net income from discontinued operations | $ | — | $ | 8,156 | $ | 25,688 | $ | 33,812 | |||||||
Three Months Ended December 31, | Year Ended December 31, | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Consolidated Statements of Income Data: | ||||||||||||||||
Net income attributable to The Ensign Group, Inc. | $ | 27,326 | $ | 26,559 | $ | 111,686 | $ | 92,528 | ||||||||
Less: net (loss)/income attributable to noncontrolling interests in continuing operations | (68 | ) | 16 | 523 | (431 | ) | ||||||||||
Less: net income from discontinued operations, net of tax | — | 8,456 | 19,473 | 33,466 | ||||||||||||
Add: Interest expense, net | 3,357 | 3,162 | 13,013 | 13,166 | ||||||||||||
Provision for income taxes | 9,010 | 2,653 | 23,954 | 12,685 | ||||||||||||
Depreciation and amortization | 13,354 | 11,544 | 51,054 | 44,864 | ||||||||||||
EBITDA from continuing operations | 53,115 | 35,446 | 179,711 | 130,208 | ||||||||||||
EBITDA from discontinued operations(g) | — | 11,001 | 26,883 | 45,460 | ||||||||||||
EBITDA | $ | 53,115 | $ | 46,447 | $ | 206,594 | $ | 175,668 | ||||||||
Adjustments to EBITDA: | ||||||||||||||||
Earnings related to operations in the start-up phase (a) | — | (3,403 | ) | — | (11,628 | ) | ||||||||||
Return of unclaimed class action settlement | — | — | — | (1,664 | ) | |||||||||||
Share-based compensation expense | 3,107 | 2,211 | 11,322 | 8,367 | ||||||||||||
Results related to closed operations and operations not at full capacity(b) | 496 | 137 | 1,680 | 601 | ||||||||||||
Acquisition related costs(c) | 132 | 10 | 277 | 322 | ||||||||||||
Spin-Off transaction costs(d) | 464 | — | 464 | — | ||||||||||||
Impairment charges to fixed assets, net of gain on sale(e) | 1,732 | 4,632 | 329 | 4,632 | ||||||||||||
Business interruption recoveries related to Hurricane Harvey and California fires | — | — | — | (675 | ) | |||||||||||
Impairment of goodwill and intangible assets(f) | 941 | — | 941 | 3,177 | ||||||||||||
Rent related to items above | 443 | 3,695 | 921 | 14,648 | ||||||||||||
Adjusted EBITDA from continuing operations | 60,430 | 42,728 | 195,645 | 147,988 | ||||||||||||
Adjusted EBITDA from discontinued operations(g) | — | 11,543 | 36,801 | 47,627 | ||||||||||||
Adjusted EBITDA | $ | 60,430 | $ | 54,271 | $ | 232,446 | $ | 195,615 | ||||||||
Rent—cost of services | 31,511 | 29,898 | 124,789 | 117,676 | ||||||||||||
Less: rent related to items above | (443 | ) | (3,695 | ) | (921 | ) | (14,648 | ) | ||||||||
Adjusted rent - cost of services | 31,068 | 26,203 | 123,868 | 103,028 | ||||||||||||
Adjusted rent included in discontinued operations | $ | — | $ | 5,432 | $ | 17,283 | $ | 20,805 | ||||||||
Adjusted EBITDAR from continuing operations | $ | 91,498 | $ | 356,314 | ||||||||||||
Adjusted EBITDAR | $ | 91,498 | $ | 373,597 | ||||||||||||
(a) | Represents results related to facilities currently in the start-up phase after construction was completed. This amount excludes rent, depreciation and interest expense. |
(b) | Results at closed operations and operations not at full capacity during the periods presented. |
(c) | Costs incurred to acquire operations which are not capitalizable. |
(d) | Costs incurred in connection with the completed Spin-Off transaction of our home health and hospice operations and substantially all of our senior living operations to a newly formed publicly traded company. Transaction costs incurred prior to Spin-Off date are included in discontinued operations as an adjustment. |
(e) | Impairment charges to fixed assets includes impairment charges of $1.7 million at one of our skilled nursing operations during the three months ended December 31, 2019. Included in the year ended December 31, 2019, impairment charges of $1.5 million at two of our senior living operations and at the skilled nursing operation mentioned, offset by the gain recognized for the sale of real estate of $2.9 million. |
(f) | Impairment charges to goodwill and intangible assets at our other ancillary operations and a skilled nursing operation. |
(g) | All adjustments included in the table below are presented within net income from discontinued operations, net of tax within the consolidated statements of income for the periods presented. |
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||
Consolidated Statements of Income Data: | |||||||||||||
Net income from discontinued operations, net of tax | $ | — | $ | 8,456 | $ | 19,473 | $ | 33,466 | |||||
Less: net income attributable to noncontrolling interests in discontinued operations | — | 183 | 629 | 595 | |||||||||
Add: Interest income, net | — | $ | (37 | ) | $ | (26 | ) | $ | (47 | ) | |||
Provision for income taxes | — | 2,110 | 5,663 | 10,156 | |||||||||
Depreciation and amortization | — | 655 | 2,402 | 2,480 | |||||||||
EBITDA from discontinued operations | $ | — | $ | 11,001 | $ | 26,883 | $ | 45,460 | |||||
Adjustments to EBITDA from discontinued operations: | |||||||||||||
Earnings related to operations in the start-up phase | — | 35 | 377 | 128 | |||||||||
Share-based compensation expense | — | 486 | 1,018 | 1,970 | |||||||||
Spin-off transaction costs | — | 13 | 7,909 | — | |||||||||
Acquisition related costs | — | — | 603 | 39 | |||||||||
Rent related to items above | — | 8 | 11 | 30 | |||||||||
Adjusted EBITDA from discontinued operations | $ | — | $ | 11,543 | $ | 36,801 | $ | 47,627 | |||||
THE ENSIGN GROUP, INC. | ||||||||||
SELECT PERFORMANCE INDICATORS | ||||||||||
(Unaudited) | ||||||||||
Three Months Ended December 31, | ||||||||||||||
2019 | 2018 | Change | % Change | |||||||||||
(Dollars in thousands) | ||||||||||||||
Total Facility Results: | ||||||||||||||
Transitional and skilled revenue | $ | 530,171 | $ | 441,714 | $ | 88,457 | 20.0 | % | ||||||
Number of facilities at period end | 190 | 168 | 22 | 13.1 | % | |||||||||
Number of campuses at period end* | 23 | 19 | 4 | 21.1 | % | |||||||||
Actual patient days | 1,591,163 | 1,393,783 | 197,380 | 14.2 | % | |||||||||
Occupancy percentage — Operational beds | 79.1 | % | 77.9 | % | 1.2 | % | ||||||||
Skilled mix by nursing days | 28.7 | % | 28.6 | % | 0.1 | % | ||||||||
Skilled mix by nursing revenue | 49.2 | % | 48.1 | % | 1.1 | % | ||||||||
Three Months Ended December 31, | ||||||||||||||
2019 | 2018 | Change | % Change | |||||||||||
(Dollars in thousands) | ||||||||||||||
Same Facility Results(1): | ||||||||||||||
Transitional and skilled revenue | $ | 372,507 | $ | 339,210 | $ | 33,297 | 9.8 | % | ||||||
Number of facilities at period end | 131 | 131 | — | — | % | |||||||||
Number of campuses at period end* | 9 | 9 | — | — | % | |||||||||
Actual patient days | 1,065,825 | 1,032,926 | 32,899 | 3.2 | % | |||||||||
Occupancy percentage — Operational beds | 80.6 | % | 78.7 | % | 1.9 | % | ||||||||
Skilled mix by nursing days | 31.2 | % | 30.4 | % | 0.8 | % | ||||||||
Skilled mix by nursing revenue | 52.0 | % | 49.9 | % | 2.1 | % | ||||||||
Three Months Ended December 31, | ||||||||||||||
2019 | 2018 | Change | % Change | |||||||||||
(Dollars in thousands) | ||||||||||||||
Transitioning Facility Results(2): | ||||||||||||||
Transitional and skilled revenue | $ | 94,778 | $ | 86,516 | $ | 8,262 | 9.5 | % | ||||||
Number of facilities at period end | 33 | 33 | — | — | ||||||||||
Number of campuses at period end* | 7 | 7 | — | — | ||||||||||
Actual patient days | 313,281 | 307,367 | 5,914 | 1.9 | % | |||||||||
Occupancy percentage — Operational beds | 77.7 | % | 76.2 | % | 1.5 | % | ||||||||
Skilled mix by nursing days | 25.4 | % | 24.4 | % | 1.0 | % | ||||||||
Skilled mix by nursing revenue | 45.5 | % | 43.8 | % | 1.7 | % | ||||||||
Three Months Ended December 31, | |||||||||||||
2019 | 2018 | Change | % Change | ||||||||||
(Dollars in thousands) | |||||||||||||
Recently Acquired Facility Results(3): | |||||||||||||
Transitional and skilled revenue | $ | 62,010 | $ | 13,017 | $ | 48,993 | NM | ||||||
Number of facilities at period end | 26 | 4 | 22 | NM | |||||||||
Number of campuses at period end* | 7 | 3 | 4 | NM | |||||||||
Actual patient days | 209,255 | 43,387 | 165,868 | NM | |||||||||
Occupancy percentage — Operational beds | 74.2 | % | 72.4 | % | NM | ||||||||
Skilled mix by nursing days | 20.9 | % | 19.8 | % | NM | ||||||||
Skilled mix by nursing revenue | 38.1 | % | 32.2 | % | NM | ||||||||
Three Months Ended December 31, | |||||||||||||
2019 | 2018 | Change | % Change | ||||||||||
(Dollars in thousands) | |||||||||||||
Facility Closed Results(4): | |||||||||||||
Transitional and skilled revenue | $ | 876 | $ | 2,971 | $ | (2,095 | ) | NM | |||||
Actual patient days | 2,802 | 10,103 | (7,301 | ) | NM | ||||||||
Occupancy percentage — Operational beds | 60.7 | % | 73.7 | % | NM | ||||||||
Skilled mix by nursing days | 13.7 | % | 15.1 | % | NM | ||||||||
Skilled mix by nursing revenue | 27.8 | % | 29.9 | % | NM | ||||||||
* | Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective reportable segment. |
(1) | Same Facility results represent all facilities purchased prior to January 1, 2016. |
(2) | Transitioning Facility results represent all facilities purchased from January 1, 2016 to December 31, 2017. |
(3) | Recently Acquired Facility (Acquisitions) results represent all facilities purchased on or subsequent to January 1, 2018. |
(4) | Facility Closed results represents closed operations during the three months ended December 31, 2019, which were excluded from Same Facilities results for the three months ended December 31, 2019 and 2018 for comparison purposes. |
Year Ended December 31, | ||||||||||||||
2019 | 2018 | Change | % Change | |||||||||||
(Dollars in thousands) | ||||||||||||||
Total Facility Results: | ||||||||||||||
Transitional and skilled revenue | $ | 1,934,640 | $ | 1,679,012 | $ | 255,628 | 15.2 | % | ||||||
Number of facilities at period end | 190 | 168 | 22 | 13.1 | % | |||||||||
Number of campuses at period end* | 23 | 19 | 4 | 21.1 | % | |||||||||
Actual patient days | 5,987,027 | 5,405,952 | 581,075 | 10.7 | % | |||||||||
Occupancy percentage — Operational beds | 79.2 | % | 77.4 | % | 1.8 | % | ||||||||
Skilled mix by nursing days | 29.0 | % | 29.5 | % | (0.5 | )% | ||||||||
Skilled mix by nursing revenue | 48.8 | % | 49.6 | % | (0.8 | )% | ||||||||
Year Ended December 31, | ||||||||||||||
2019 | 2018 | Change | % Change | |||||||||||
(Dollars in thousands) | ||||||||||||||
Same Facility Results(1): | ||||||||||||||
Transitional and skilled revenue | $ | 1,410,718 | $ | 1,307,882 | $ | 102,836 | 7.9 | % | ||||||
Number of facilities at period end | 131 | 131 | — | — | % | |||||||||
Number of campuses at period end* | 9 | 9 | — | — | % | |||||||||
Actual patient days | 4,199,374 | 4,070,122 | 129,252 | 3.2 | % | |||||||||
Occupancy percentage — Operational beds | 80.3 | % | 78.2 | % | 2.1 | % | ||||||||
Skilled mix by nursing days | 31.1 | % | 31.2 | % | (0.1 | )% | ||||||||
Skilled mix by nursing revenue | 51.2 | % | 51.1 | % | 0.1 | % | ||||||||
Year Ended December 31, | ||||||||||||||
2019 | 2018 | Change | % Change | |||||||||||
(Dollars in thousands) | ||||||||||||||
Transitioning Facility Results(2): | ||||||||||||||
Transitional and skilled revenue | $ | 364,337 | $ | 330,795 | $ | 33,542 | 10.1 | % | ||||||
Number of facilities at period end | 33 | 33 | — | — | ||||||||||
Number of campuses at period end* | 7 | 7 | — | — | ||||||||||
Actual patient days | 1,247,573 | 1,201,138 | 46,435 | 3.9 | % | |||||||||
Occupancy percentage — Operational beds | 78.1 | % | 75.3 | % | 2.8 | % | ||||||||
Skilled mix by nursing days | 25.5 | % | 25.2 | % | 0.3 | % | ||||||||
Skilled mix by nursing revenue | 44.9 | % | 45.2 | % | (0.3 | )% | ||||||||
Year Ended December 31, | |||||||||||||
2019 | 2018 | Change | % Change | ||||||||||
(Dollars in thousands) | |||||||||||||
Recently Acquired Facility Results(3): | |||||||||||||
Transitional and skilled revenue | $ | 149,995 | $ | 28,580 | $ | 121,415 | NM | ||||||
Number of facilities at period end | 26 | 4 | 22 | NM | |||||||||
Number of campuses at period end* | 7 | 3 | 4 | NM | |||||||||
Actual patient days | 510,541 | 95,034 | 415,507 | NM | |||||||||
Occupancy percentage — Operational beds | 74.0 | % | 73.9 | % | NM | ||||||||
Skilled mix by nursing days | 20.9 | % | 20.5 | % | NM | ||||||||
Skilled mix by nursing revenue | 36.4 | % | 33.4 | % | NM | ||||||||
Year Ended December 31, | |||||||||||||
2019 | 2018 | Change | % Change | ||||||||||
(Dollars in thousands) | |||||||||||||
Facility Closed Results(4): | |||||||||||||
Transitional and skilled revenue | $ | 9,590 | $ | 11,755 | $ | (2,165 | ) | NM | |||||
Actual patient days | 29,539 | 39,658 | (10,119 | ) | NM | ||||||||
Occupancy percentage — Operational beds | 65.2 | % | 72.9 | % | NM | ||||||||
Skilled mix by nursing days | 17.0 | % | 16.1 | % | NM | ||||||||
Skilled mix by nursing revenue | 34.4 | % | 33.4 | % | NM | ||||||||
* | Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective reportable segment. |
(1) | Same Facility results represent all facilities purchased prior to January 1, 2016. |
(2) | Transitioning Facility results represent all facilities purchased from January 1, 2016 to December 31, 2017. |
(3) | Recently Acquired Facility (Acquisitions) results represent all facilities purchased on or subsequent to January 1, 2018. |
(4) | Facility Closed results represents closed operations during the year ended December 31, 2019, which were excluded from Same Facilities results for the year ended December 31, 2019 and 2018 for comparison purposes. |
Three Months Ended December 31, | |||||||||||||||||||||||||||||||
Same Facility | Transitioning | Acquisitions | Total | ||||||||||||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||||||||||
Skilled Nursing Average Daily Revenue Rates: | |||||||||||||||||||||||||||||||
Medicare | $ | 669.99 | $ | 611.29 | $ | 566.96 | $ | 529.04 | $ | 615.07 | $ | 520.12 | $ | 642.11 | $ | 590.27 | |||||||||||||||
Managed care | 486.07 | 461.46 | 429.96 | 415.66 | 439.18 | 424.28 | 470.83 | 450.91 | |||||||||||||||||||||||
Other skilled | 511.16 | 485.01 | 495.11 | 581.69 | 323.27 | 249.05 | 501.46 | 486.26 | |||||||||||||||||||||||
Total skilled revenue | 563.23 | 526.39 | 502.37 | 480.00 | 518.43 | 458.20 | 548.33 | 516.35 | |||||||||||||||||||||||
Medicaid | 237.78 | 232.72 | 208.42 | 200.45 | 224.69 | 240.55 | 230.12 | 225.68 | |||||||||||||||||||||||
Private and other payors | 226.89 | 228.35 | 195.88 | 194.95 | 211.72 | 237.21 | 216.97 | 219.89 | |||||||||||||||||||||||
Total skilled nursing revenue | $ | 338.08 | $ | 321.86 | $ | 281.18 | $ | 268.05 | $ | 284.27 | $ | 283.32 | $ | 319.72 | $ | 308.52 | |||||||||||||||
Year Ended December 31, | |||||||||||||||||||||||||||||||
Same Facility | Transitioning | Acquisitions | Total | ||||||||||||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||||||||||
Skilled Nursing Average Daily Revenue Rates: | |||||||||||||||||||||||||||||||
Medicare | $ | 628.20 | $ | 600.65 | $ | 542.67 | $ | 520.85 | $ | 594.74 | $ | 528.11 | $ | 607.24 | $ | 580.96 | |||||||||||||||
Managed care | 470.85 | 457.09 | 420.48 | 410.87 | 432.41 | 423.94 | 458.26 | 447.34 | |||||||||||||||||||||||
Other skilled | 496.37 | 475.12 | 491.15 | 522.24 | 327.22 | 246.85 | 490.93 | 475.59 | |||||||||||||||||||||||
Total skilled revenue | 537.00 | 517.86 | 484.13 | 473.60 | 501.13 | 460.52 | 525.41 | 509.10 | |||||||||||||||||||||||
Medicaid | 232.41 | 225.48 | 203.99 | 193.18 | 231.46 | 235.70 | 226.43 | 218.30 | |||||||||||||||||||||||
Private and other payors | 231.87 | 225.31 | 202.19 | 198.33 | 229.17 | 237.61 | 223.97 | 218.42 | |||||||||||||||||||||||
Total skilled nursing revenue | $ | 327.48 | $ | 317.01 | $ | 275.25 | $ | 264.81 | $ | 287.52 | $ | 282.07 | $ | 313.11 | $ | 304.57 | |||||||||||||||
Three Months Ended December 31, | |||||||||||||||||||||||
Same Facility | Transitioning | Acquisitions | Total | ||||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||
Percentage of Skilled Nursing Revenue: | |||||||||||||||||||||||
Medicare | 24.2 | % | 23.2 | % | 26.0 | % | 25.2 | % | 22.8 | % | 17.4 | % | 24.3 | % | 23.4 | % | |||||||
Managed care | 17.9 | 17.0 | 17.4 | 17.0 | 13.2 | 13.6 | 17.3 | 16.9 | |||||||||||||||
Other skilled | 9.9 | 9.7 | 2.1 | 1.6 | 2.1 | 1.2 | 7.6 | 7.8 | |||||||||||||||
Skilled mix | 52.0 | 49.9 | 45.5 | 43.8 | 38.1 | 32.2 | 49.2 | 48.1 | |||||||||||||||
Private and other payors | 7.4 | 7.5 | 11.1 | 11.0 | 9.8 | 13.1 | 8.4 | 8.4 | |||||||||||||||
Medicaid | 40.6 | 42.6 | 43.4 | 45.2 | 52.1 | 54.7 | 42.4 | 43.5 | |||||||||||||||
Total skilled nursing | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||
Three Months Ended December 31, | |||||||||||||||||||||||
Same Facility | Transitioning | Acquisitions | Total | ||||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||
Percentage of Skilled Nursing Days: | |||||||||||||||||||||||
Medicare | 12.2 | % | 12.2 | % | 12.9 | % | 12.8 | % | 10.6 | % | 9.5 | % | 12.1 | % | 12.2 | % | |||||||
Managed care | 12.5 | 11.8 | 11.4 | 10.9 | 8.6 | 9.0 | 11.7 | 11.5 | |||||||||||||||
Other skilled | 6.5 | 6.4 | 1.1 | 0.7 | 1.7 | 1.3 | 4.9 | 4.9 | |||||||||||||||
Skilled mix | 31.2 | 30.4 | 25.4 | 24.4 | 20.9 | 19.8 | 28.7 | 28.6 | |||||||||||||||
Private and other payors | 11.1 | 11.0 | 16.1 | 15.2 | 13.2 | 16.0 | 12.3 | 12.2 | |||||||||||||||
Medicaid | 57.7 | 58.6 | 58.5 | 60.4 | 65.9 | 64.2 | 59.0 | 59.2 | |||||||||||||||
Total skilled nursing | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||
Year Ended December 31, | |||||||||||||||||||||||
Same Facility | Transitioning | Acquisitions | Total | ||||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||
Percentage of Skilled Nursing Revenue: | |||||||||||||||||||||||
Medicare | 23.2 | % | 23.6 | % | 25.1 | % | 26.8 | % | 20.6 | % | 17.9 | % | 23.4 | % | 24.2 | % | |||||||
Managed care | 18.4 | 18.1 | 18.1 | 16.9 | 13.8 | 14.4 | 17.9 | 17.7 | |||||||||||||||
Other skilled | 9.6 | 9.4 | 1.7 | 1.5 | 2.0 | 1.1 | 7.5 | 7.7 | |||||||||||||||
Skilled mix | 51.2 | 51.1 | 44.9 | 45.2 | 36.4 | 33.4 | 48.8 | 49.6 | |||||||||||||||
Private and other payors | 7.5 | 7.6 | 11.3 | 11.5 | 11.0 | 14.1 | 8.5 | 8.5 | |||||||||||||||
Medicaid | 41.3 | 41.3 | 43.8 | 43.3 | 52.6 | 52.5 | 42.7 | 41.9 | |||||||||||||||
Total skilled nursing | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||
Year Ended December 31, | |||||||||||||||||||||||
Same Facility | Transitioning | Acquisitions | Total | ||||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||
Percentage of Skilled Nursing Days: | |||||||||||||||||||||||
Medicare | 12.1 | % | 12.4 | % | 12.7 | % | 13.6 | % | 10.0 | % | 9.5 | % | 12.0 | % | 12.6 | % | |||||||
Managed care | 12.7 | 12.5 | 11.8 | 10.8 | 9.2 | 9.6 | 12.2 | 12.0 | |||||||||||||||
Other skilled | 6.3 | 6.3 | 1.0 | 0.8 | 1.7 | 1.4 | 4.8 | 4.9 | |||||||||||||||
Skilled mix | 31.1 | 31.2 | 25.5 | 25.2 | 20.9 | 20.5 | 29.0 | 29.5 | |||||||||||||||
Private and other payors | 10.8 | 11.0 | 15.6 | 15.6 | 13.9 | 16.8 | 12.1 | 12.2 | |||||||||||||||
Medicaid | 58.1 | 57.8 | 58.9 | 59.2 | 65.2 | 62.7 | 58.9 | 58.3 | |||||||||||||||
Total skilled nursing | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||
Three Months Ended December 31, | Year Ended December 31, | |||||||||||||||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||||||||||||||
$ | % | $ | % | $ | % | $ | % | |||||||||||||||||||||
(Dollars in thousands) | (Dollars in thousands) | |||||||||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||||||
Medicaid | $ | 216,729 | 38.7 | % | $ | 188,058 | 40.7 | % | $ | 802,952 | 39.4 | % | $ | 691,276 | 39.4 | % | ||||||||||||
Medicare | 144,213 | 25.7 | 112,884 | 24.4 | 499,353 | 24.5 | 436,580 | 24.9 | ||||||||||||||||||||
Medicaid-skilled | 36,567 | 6.5 | 31,662 | 6.9 | 132,889 | 6.5 | 117,686 | 6.7 | ||||||||||||||||||||
Total Medicaid and Medicare | 397,509 | 70.9 | 332,604 | 72.0 | 1,435,194 | 70.4 | 1,245,542 | 71.0 | ||||||||||||||||||||
Managed Care | 92,849 | 16.6 | 76,002 | 16.4 | 351,054 | 17.2 | 301,866 | 17.2 | ||||||||||||||||||||
Private and Other(1) | 69,833 | 12.5 | 53,833 | 11.6 | 250,276 | 12.4 | 207,193 | 11.8 | ||||||||||||||||||||
Revenue | $ | 560,191 | 100.0 | % | $ | 462,439 | 100.0 | % | $ | 2,036,524 | 100.0 | % | $ | 1,754,601 | 100.0 | % | ||||||||||||
(1) Private and other payors also includes revenue from all payors generated in our other ancillary services for the three months and years ended December 31, 2019 and 2018. During the fiscal year 2019, private and other payors includes $5,812 of rental income. | ||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||
3/31/2019 | 6/30/2019 | 9/30/2019 | 12/31/2019 | ||||||||||||
Net income from continuing operations | $ | 21,480 | $ | 20,668 | $ | 22,148 | $ | 27,394 | |||||||
Net income from discontinued operations, net of tax | 5,892 | 7,941 | 5,011 | — | |||||||||||
Net income attributable to The Ensign Group, Inc. | $ | 27,372 | $ | 28,609 | $ | 27,159 | $ | 27,394 | |||||||
Non-GAAP adjustments | |||||||||||||||
Share-based compensation expense(a) | 2,456 | 2,930 | 2,829 | 3,107 | |||||||||||
Results related to closed operations and operations not at full capacity(b) | 349 | 626 | 1,219 | 1,311 | |||||||||||
Acquisition related costs(c) | 26 | 49 | 69 | 132 | |||||||||||
Depreciation and amortization - patient base(d) | 70 | 87 | 104 | 260 | |||||||||||
General and administrative - Spin-Off transaction costs(e) | — | — | — | 464 | |||||||||||
COS - (gain on sale)/impairment charges to fixed assets(f) | — | — | (1,402 | ) | 1,732 | ||||||||||
COS - impairment of goodwill and intangibles(g) | — | — | — | 941 | |||||||||||
Interest expense - write off of deferred financing fee(h) | — | — | — | 329 | |||||||||||
Provision for income taxes on Non-GAAP adjustments(i) | (2,161 | ) | (2,687 | ) | (2,520 | ) | (2,141 | ) | |||||||
Non-GAAP income from continuing operations | $ | 22,220 | $ | 21,673 | $ | 22,447 | $ | 33,529 | |||||||
Non-GAAP income from discontinued operations | 8,583 | 8,609 | 8,496 | — | |||||||||||
Non-GAAP net income | $ | 30,803 | $ | 30,282 | $ | 30,943 | $ | 33,529 | |||||||
Average number of shares outstanding | 55,698 | 56,078 | 56,364 | 55,760 | |||||||||||
Diluted Earnings Per Share As Reported | |||||||||||||||
Continuing operations | $ | 0.39 | $ | 0.37 | $ | 0.39 | $ | 0.49 | |||||||
Discontinued operations | $ | 0.10 | $ | 0.14 | $ | 0.09 | $ | — | |||||||
Diluted income per share attributable to The Ensign Group, Inc. | $ | 0.49 | $ | 0.51 | $ | 0.48 | $ | 0.49 | |||||||
Adjusted Diluted Earnings Per Share | |||||||||||||||
Continuing operations | $ | 0.40 | $ | 0.39 | $ | 0.40 | $ | 0.60 | |||||||
Discontinued operations | $ | 0.15 | $ | 0.15 | $ | 0.15 | $ | — | |||||||
Diluted income per share attributable to The Ensign Group, Inc. | $ | 0.55 | $ | 0.54 | $ | 0.55 | $ | 0.60 | |||||||
Footnotes: | |||||||||||||||
(a) Represents share-based compensation expense incurred. | |||||||||||||||
Three Months Ended | |||||||||||||||
3/31/2019 | 6/30/2019 | 9/30/2019 | 12/31/2019 | ||||||||||||
Cost of services | $ | 1,516 | $ | 1,779 | $ | 1,740 | $ | 2,001 | |||||||
General and administrative | 940 | 1,151 | 1,089 | 1,106 | |||||||||||
Total Non-GAAP adjustment | $ | 2,456 | $ | 2,930 | $ | 2,829 | $ | 3,107 | |||||||
(b) Represents results at closed operations and operations not at full capacity | |||||||||||||||
Three Months Ended | |||||||||||||||
3/31/2019 | 6/30/2019 | 9/30/2019 | 12/31/2019 | ||||||||||||
Revenue | $ | — | $ | (1,830 | ) | $ | (2,567 | ) | $ | (4,212 | ) | ||||
Cost of services | 264 | 2,195 | 3,122 | 4,708 | |||||||||||
Rent | 76 | 107 | 295 | 443 | |||||||||||
Depreciation and amortization | 9 | 154 | 369 | 372 | |||||||||||
Total Non-GAAP adjustment | $ | 349 | $ | 626 | $ | 1,219 | $ | 1,311 | |||||||
(c) Represents costs incurred to acquire an operation which are not capitalizable. | |||||||||||||||
(d) Included in depreciation and amortization are expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities. | |||||||||||||||
(e) Included in general and administrative expense are costs incurred in connection with the completed Spin-Off of our home health and hospice operations and substantially all of our senior living operations to a newly formed publicly traded company subsequent to the Spin-Off date. | |||||||||||||||
(f) Impairment charges to fixed assets includes impairment charges of $1.7 million at a leased skilled nursing operations during the three months ended December 31, 2019. Included in the three months ended September 30, 2019, impairment charges of $1.5 million at two of our senior living operations, offset by the gain recognized for the sale of real estate of $2.9 million. | |||||||||||||||
(g) Impairment charges to goodwill and intangible assets at our other ancillary operations and a skilled nursing operation. | |||||||||||||||
(h) Represents the write off of deferred financing fees associated with the amendment of the credit facility. | |||||||||||||||
(i) Represents an adjustment to the provision for income tax to our historical year to date effective tax rate of 25.0% for the periods presented. | |||||||||||||||
(j) Represents results of the home health, hospice and senior living operations we transferred to the Pennant Group, Inc. as a result of the Spin-Off. | |||||||||||||||
Three Months Ended | |||||||||||||||
3/31/2019 | 6/30/2019 | 9/30/2019 | 12/31/2019 | ||||||||||||
Revenue | $ | 77,730 | $ | 82,658 | $ | 88,325 | $ | — | |||||||
Cost of services | (57,448 | ) | (61,534 | ) | (66,981 | ) | — | ||||||||
General and administrative expenses | (2,393 | ) | (2,752 | ) | (2,892 | ) | — | ||||||||
Rent | (5,598 | ) | (5,836 | ) | (5,849 | ) | — | ||||||||
Depreciation and amortization | (658 | ) | (800 | ) | (909 | ) | — | ||||||||
Interest income, net | 11 | 9 | 6 | — | |||||||||||
Provision for income taxes | (2,911 | ) | (2,936 | ) | (2,925 | ) | — | ||||||||
Non-controlling interest | (150 | ) | (200 | ) | (279 | ) | — | ||||||||
Non-GAAP net income from discontinued operations | $ | 8,583 | $ | 8,609 | $ | 8,496 | $ | — | |||||||
Three Months Ended | ||||||||||||||||
3/31/2019 | 6/30/2019 | 9/30/2019 | 12/31/2019 | |||||||||||||
Consolidated Statements of Income Data: | ||||||||||||||||
Net income attributable to The Ensign Group, Inc. | $ | 27,607 | $ | 28,925 | $ | 27,828 | $ | 27,326 | ||||||||
Less: net income/(loss) attributable to noncontrolling interests in continuing operations | 85 | 116 | 390 | (68 | ) | |||||||||||
Less: net income from discontinued operations, net of tax | 6,042 | 8,141 | 5,290 | — | ||||||||||||
Add: Interest expense, net | 3,109 | 3,379 | 3,168 | 3,357 | ||||||||||||
Provision for income taxes | 5,275 | 4,576 | 5,093 | 9,010 | ||||||||||||
Depreciation and amortization | 11,929 | 12,366 | 13,405 | 13,354 | ||||||||||||
EBITDA from continuing operations | 41,793 | 40,989 | 43,814 | 53,115 | ||||||||||||
EBITDA from discontinued operations | 8,374 | 9,725 | 8,781 | — | ||||||||||||
EBITDA | $ | 50,167 | $ | 50,714 | $ | 52,595 | $ | 53,115 | ||||||||
Adjustments to EBITDA: | ||||||||||||||||
Share-based compensation expense | 2,456 | 2,930 | 2,829 | 3,107 | ||||||||||||
Results related to closed operations and operations not at full capacity(a) | 264 | 365 | 555 | 496 | ||||||||||||
Acquisition related costs(b) | 26 | 49 | 69 | 132 | ||||||||||||
Spin-Off transaction costs(c) | — | — | — | 464 | ||||||||||||
(Gain on sale)/impairment charges to fixed assets(d) | — | — | (1,402 | ) | 1,732 | |||||||||||
Impairment of goodwill and intangible assets(e) | — | — | — | 941 | ||||||||||||
Rent related to items above | 76 | 107 | 295 | 443 | ||||||||||||
Adjusted EBITDA from continuing operations | 44,615 | 44,440 | 46,160 | 60,430 | ||||||||||||
Adjusted EBITDA from discontinued operations(f) | 12,141 | 12,336 | 12,324 | — | ||||||||||||
Adjusted EBITDA | $ | 56,756 | $ | 56,776 | $ | 58,484 | $ | 60,430 | ||||||||
Rent—cost of services | 30,181 | 31,222 | 31,875 | 31,511 | ||||||||||||
Less: rent related to items above | (76 | ) | (107 | ) | (295 | ) | (443 | ) | ||||||||
Adjusted rent - cost of services | $ | 30,105 | $ | 31,115 | 31,580 | 31,068 | ||||||||||
Adjusted rent included in discontinued operations | $ | 5,598 | $ | 5,836 | $ | 5,849 | $ | — | ||||||||
Adjusted EBITDAR from continuing operations | 74,720 | 75,555 | 77,740 | 91,498 | ||||||||||||
Adjusted EBITDAR | $ | 92,459 | $ | 93,727 | $ | 95,913 | $ | 91,498 | ||||||||
(a) | Results at closed operations and operations not at full capacity during the periods presented. |
(b) | Costs incurred to acquire operations which are not capitalizable. |
(d) | Impairment charges to fixed assets includes impairment charges of $1.7 million at one of our skilled nursing operations during the three months ended December 31, 2019. Included in the three months ended September 30, 2019, impairment charges of $1.5 million at two of our senior living operations, offset by the gain recognized for the sale of real estate of $2.9 million. |
Three Months Ended December 31, | |||||||||||||||
3/31/2019 | 6/30/2019 | 9/30/2019 | 12/31/2019 | ||||||||||||
Consolidated Statements of Income Data: | |||||||||||||||
Net income from discontinued operations, net of tax | $ | 6,042 | $ | 8,141 | $ | 5,290 | $ | — | |||||||
Less: net income attributable to noncontrolling interests in discontinued operations | 150 | 200 | 279 | — | |||||||||||
Add: Interest income, net | (12 | ) | (10 | ) | (4 | ) | — | ||||||||
Provision for income taxes | 1,825 | 976 | 2,860 | — | |||||||||||
Depreciation and amortization | 669 | 818 | 914 | — | |||||||||||
EBITDA from discontinued operations | $ | 8,374 | $ | 9,725 | $ | 8,781 | $ | — | |||||||
Adjustments to EBITDA from discontinued operations: | |||||||||||||||
Earnings related to operations in the start-up phase | 236 | 82 | 59 | — | |||||||||||
Share-based compensation expense | 497 | 372 | 149 | — | |||||||||||
Spin-Off transaction costs | 2,990 | 1,658 | 3,261 | — | |||||||||||
Acquisition related costs | 36 | 497 | 70 | — | |||||||||||
Rent related to items above | 8 | 2 | 4 | — | |||||||||||
Adjusted EBITDA from discontinued operations | $ | 12,141 | $ | 12,336 | $ | 12,324 | $ | — | |||||||